Making Science Investable SRL
Making Science Investable reported total assets of 430,600 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Mar 2026).
The score of Making Science Investable shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Total assets +42917 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Making Science Investable's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Mar 2026
- Year ended 31 Dec 2024filed on 09 Jul 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
Making Science Investable's financial analysis
- Solvency73.8%sector median: 26.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Making Science Investable
Making Science Investable's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.220.529
- VAT number
- BE1002220529
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 13 Nov 2023
- Registered office
- 1150 Woluwe-Saint-Pierre
- Latest accounts
- 2025 · filed on 06 Mar 2026
- Activity
- Fund management activities (NACE 66300)
Making Science Investable (SRL) has been based in Woluwe-Saint-Pierre since 2023, active in: fund management activities. For 2025, it reports a net profit of 185,111 € and equity of 317,621 €; its revenue is not published. Its solvency stands at 73.8%, above the median of its sector (26.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Making Science Investable
Companies in the same business, of comparable size and area, outside its group.
- Bureau Nijs Other financial service activities, except insurance and pension funding n.e.c. Lasne · balance sheet 431,666 €
- Abeco Other credit granting Hasselt · balance sheet 426,276 €
- Verzekeringshuis Other financial service activities, except insurance and pension funding n.e.c. Genk · balance sheet 426,164 €
- Zakenkantoor Ronny Huyghe Other financial service activities, except insurance and pension funding n.e.c. Gistel · balance sheet 435,637 €
- J. Degryse & Co Financial leasing Bonheiden · balance sheet 435,866 €
- Huguet - Lucas Other credit granting Péruwelz · balance sheet 424,306 €
- Maifin Financial leasing La Louvière · balance sheet 437,079 €
- Apex Immo 1 Financial leasing Waterloo · balance sheet 423,771 €
Frequently asked questions about Making Science Investable
What is the revenue of Making Science Investable?
Making Science Investable files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Making Science Investable?
In Belgium, the VAT number is the company number prefixed with BE: BE1002220529 for Making Science Investable, if the company is VAT-registered. Its company number (CBE) is 1002.220.529.
Where is the registered office of Making Science Investable?
According to the CBE register, the registered office of Making Science Investable is in 1150 Woluwe-Saint-Pierre.
What is the equity of Making Science Investable?
At the close of the 2025 financial year, the equity of Making Science Investable amounts to 317,621 €, a solvency of 73.8% of total assets.
Who manages Making Science Investable?
The register lists 1 active mandates at Making Science Investable. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Making Science Investable
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →